Lumretuzumab

Lumretuzumab (INN; development code RG7116) is a humanized monoclonal antibody designed for the treatment of cancer.[1][2]

Lumretuzumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetERBB3
Clinical data
Other namesRG7116
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6512H10064N1736O2052S44
Molar mass146916.88 g·mol−1

This drug was developed by Genentech/Roche.

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.